MedPath

Pre-pectoral Breast Reconstruction With or Without Mesh

Not Applicable
Recruiting
Conditions
Prepectoral Breast Reconstruction
TiLOOP Mesh
Interventions
Procedure: prepectoral breast reconstruction
Procedure: Tiloop Mesh implantation
Registration Number
NCT05888571
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Brief Summary

To explore the efficacy and safety that occur after immediate prepectoral breast reconstruction when TiLOOP Mesh is used compared to that when TiLOOP Mesh is not used.

Detailed Description

The clinical study aims to explore the efficacy and safety that occur after immediate prepectoral breast reconstruction when TiLOOP Mesh is used compared to that not using TiLOOP Mesh.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
164
Inclusion Criteria
  1. Adult women aged 18-65 years who plan to undergo unilateral or bilateral immediate prepectoral prothesis breast reconstruction;
  2. SSM or NSM or Skin-Reducing Mastectomy for breast cancer patients or prophylactic mastectomy;
  3. Tissue expander size =<800cc, implant size =<600cc;
  4. The blood perfusion of breast skin flap was well;
  5. Do not smoking in the last 4 weeks or more
  6. Patients with normal expectations and mental health for breast reconstruction;
  7. Signed consent to participate
Exclusion Criteria
  1. Poor perfusion of breast mastectomy flap;
  2. II stage breast reconstruction patients;
  3. History of chest radiotherapy;
  4. BMI greater than 35;
  5. Patients who have not quit smoking within the last 4 weeks;

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
prepectoral breast reconstruction with MeshTiloop Mesh implantationImmediate prepectoral breast reconstruction with Mesh
prepectoral breast reconstruction with Meshprepectoral breast reconstructionImmediate prepectoral breast reconstruction with Mesh
prepectoral breast reconstruction without Meshprepectoral breast reconstructionImmediate prepectoral breast reconstruction without Mesh
Primary Outcome Measures
NameTimeMethod
Major Complication Ratesup to 12 months after surgery

The rate of major complications in the two groups

Patient Breast-Q questionnaireup to 12 months after surgery

We use the Breast-Q questionnaire to evaluate patients' satisfaction via the reconstruction module of BREAST-Q.

Secondary Outcome Measures
NameTimeMethod
The rate of surgical revision of reconstructed breastsup to 12 months after surgery

To record the rate of surgical revision events of the reconstructed breasts

Rates of capsule contractureup to 24 months after surgery

The rates of capsule contracture in the two groups

The rate of implant or tissue expander removalup to 12 months after surgery

The rate of implant or tissue expander removal in the two groups

Minor Complication Ratesup to 12 months after surgery

The rate of minor complications in the two groups

Trial Locations

Locations (1)

Tianjin Medical University Cancer Institute and Hospital

🇨🇳

Tianjin, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath